AKT1 and Miyoshi myopathy: The results indicated that DMEC exhibited a notably antiproliferative effect against MM cell lines, including RPMI8226, MM.1S, and U266, by inducing mitochondria-mediated apoptosis via inhibition on the PI3K/Akt/mTOR signaling pathway.